NVS (NVS) Stock Price & Analysis
NVS (NVS) rose 0.00% to USD 155.01 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
NVS last closed at USD 155.01; the session ranged USD 154.44–156.37 on volume of 1,722,259 shares. Market capitalization is —, with a 52-week range of USD 112.34–170.46 (NYQ). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 155.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 155.01 |
| Open | USD 155.01 |
| Day Range | USD 154.44 – 156.37 |
| 52-Week Range | USD 112.34 – 170.46 |
| Volume | 1,722,259 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (NVS)
Nexqual's technical model rates NVS "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.88 (neutral) |
| vs SMA50 | Above (USD 151.71) |
| MACD | 0.52 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNY | Sanofi | USD 43.35 | ▼ 1% |
| GSK | GSK plc | USD 51.35 | ▲ 1.16% |
| AZN | AstraZeneca PLC | USD 169.26 | ▼ 0.28% |
| RHHBY | Roche Holding Ltd | USD 54.7 | ▲ 5.8% |
| BMY | Bristol-Myers Squibb Company | USD 62.09 | ▲ 2.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.